Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Alvotech Hf has 1 pending office action. This matter is assigned to a distinct examiner, Amy Rose Hudson. As the busiest examiner for the company, Amy Rose Hudson is responsible for the 1 pending office action. The data indicates that there are 0 distinct art units associated with this pending matter.
With only a single pending office action, the company's prosecution activity is currently minimal. The reliance on a distinct examiner means that the outcome of this specific patent application depends entirely on the review of Amy Rose Hudson. This centralized prosecution path for Alvotech Hf simplifies the communication process but focuses all risk on a single examiner's decision.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUDSON, AMY ROSE | 1 | 74.8% | +11.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694642 | DNA CONSTRUCTS AND HOST CELLS FOR EXPRESSING RECOMBINANT PROTEIN | HUDSON, AMY ROSE | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18694642 | DNA CONSTRUCTS AND HOST CELLS FOR EXPRESSING RECOMBINANT PROTEIN | HUDSON, AMY ROSE | — | §112 | Non-Final OA | — | Pending | Mar 22, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAlvotech Hf has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Amy Rose Hudson has the most, with 1 of Alvotech Hf's pending office actions.